MADISON, Wis., Oct. 29, 2019 /PRNewswire/ -- (NASDAQ: EXAS) – Promising research from Exact Sciences Corp. and Mayo Clinic shows new methylation and protein markers detect colorectal cancer and ...
Researchers have developed a non-invasive stool test that detects colorectal cancer with nearly 90% accuracy by analyzing gut bacteria at the subspecies level. This innovative test offers a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback